Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation

NCT07521618 · Guangzhou Medical University · Updated 13 April 2026

What is being tested
Ablation
For
Lung Cancer (Suspected or Confirmed); Cryoablation; Robotic Bronchoscopy System; Confocal Laser Endomicroscopy
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 30 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 April 2026, ends 31 Dec 2026. Registered 13 April 2026.
Results
None posted yet.

In the researchers' words

Using RBS as the navigation and treatment platform, precisely navigate to the target lesion. Utilize r-EUBS and nCLE to identify the lesion, and when the confocal AI model recognizes the lesion as malignant, perform a biopsy. Subsequently, under the guidance of OBCT, carry out ablation treatment of the lesion.
ClinicalTrials.gov, NCT07521618